COVID-19: COVID-19 public health information from the US CDC | COVID-19 research information from the US NIH | Español | COVID-19 resources for global health researchers

Reducing Stigma to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle-Income Countries

Status: Not accepting applications at this time

Announcement(s)

• Funding concept: Interventions for Stigma Reduction to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle- Income Countries, presented to the Fogarty Advisory Board February 2021
• Expired announcement: Reducing Stigma to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle-Income Countries (R21 Clinical Trial Optional) (PAR-19-326)

Deadlines

• Most recent application due date: November 12, 2020

Eligibility

• Applications from non-domestic entities are restricted to higher education institutions and other non-profit organizations in LMICs, which are defined by The World Bank as low-, lower-middle- or upper-middle-income economies.
• One or more investigators from an institution in the U.S. and one or more from an institution in an LMIC are strongly encouraged to collaborate on the application.
• View full eligibility details in the program announcement.

Program Overview

Reducing Stigma to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle-Income Countries (LMICs) seeks to stimulate new and impactful research towards the development of stigma reduction interventions leading to better outcomes for the prevention and treatment of HIV/AIDS and on the quality of life of People Living with HIV/AIDS (PLWH) in LMICs.

Proposed collaborative exploratory research is expected to help build the capacity for full research programs by improving the research environment and strengthening LMIC individual and institutional research capabilities in the proposed research areas. 

Recent Awards

View a full list of Reducing Stigma to Improve HIV/AIDS Prevention, Treatment and Care in LMICs awards.

Frequently Asked Questions

Review answers to frequently asked questions for applicants to Reducing Stigma to Improve HIV/AIDS Prevention, Treatment and Care in LMICs.

Inquiries

Programmatic Issues

Geetha Bansal, Ph.D.
Program Officer
Division of International Training and Research
Fogarty International Center
National Institutes of Health
Building 31, Room B2C39
31 Center Drive, MSC 2220
Bethesda, MD 20892-2220 USA
Phone: 301-496-1492
Fax: 301-402-0779
Email: geetha.bansal@nih.gov

Grants Management

Mollie Shea
Grants Management Specialist
Fogarty International Center
National Institutes of Health
Building 31, Room B2C29
31 Center Drive, MSC 2220
Bethesda, MD 20892-2220
Telephone: 301-496-9750
Fax: 301-594-1211
Email: Mollie.Shea@nih.gov

Partners

This announcement is issued by Fogarty in collaboration with the following NIH Institutes and Offices:

• National Cancer Institute (NCI)
• Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
• National Institute of Mental Health (NIMH)
• National Institute on Drug Abuse (NIDA)
• NIH Office of Behavioral and Social Sciences Research (OBSSR)

Archives

• Fogarty launches program to reduce HIV/AIDS stigma, lower disease transmission
  Jul / Aug 2018 Global Health Matters
• Expired announcement: Reducing Stigma to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle-Income Countries (R21 Clinical Trial Optional) (PAR-18-732)
• Expired announcement: Reducing Stigma to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle-Income Countries (R21) (PAR-17-474)
• Notice of NCI's participation in PAR-17-474 "Reducing Stigma to Improve HIV/AIDS Prevention, Treatment, and Care in Low and Middle-Income Countries (R21)" (NOT-CA-17-095)

Related Global Health Research Topics

• HIV / AIDS

Last Updated: 4/23/2021 8:37 AM